New Venture Formation: Strategic Decisions

The Office of Technology Commercialization

Presents

Invention 2 Innovation (I2I)

“New Venture Formation: Strategic Decisions”

Thursday, November 19, 2015
12:00-1:30pm
Leavey Program Room at the Leavey Center
(across from the bookstore)

Have you ever wondered:

• What are some high-level considerations for choosing between an LLC or corporate entity structure?
• How can academic founders structure their new relationship to minimize tensions that inevitably arise?
• What are some key considerations for distributing equity in a new venture?
• What are some practical advantages and downsides for funding sources including convertible debt, angel rounds and grant funding?
• What are some high level considerations for choosing between an operating or virtual operating model?
• How can a company manage costs for IP, consultants and other high-priced advisors?

Presented by:

Michael Christini, Esq.
CEO and Founder
Catherex, Inc.

Catherex is a clinical stage oncology company developing oncolytic HSV for treatment of glioblastoma and other indications.  As a founder of Catherex, Michael has been involved in all aspects of formation, intellectual property licensing, fundraising and product development.  Michael attended Case Western Reserve University Law School and St. Bonaventure University.

Lunch is provided and space is limited
Please RSVP by Tuesday, November 17, 2015
to Jeremy S. Alexander at jsa [at] georgetown [dot] edu or 202.687.7424.

Faculty, entrepreneurs, fellows, students, and research administrators should attend.